MONDAY, Aug. 28, 2017 -- Move over, statins: New research finds that a medication aimed at dampening the body's inflammatory response may be a new tool to curb heart disease.
The findings were presented Sunday at the European Society of Cardiology (ESC) Congress in Barcelona, Spain, and published in two major medical journals, The Lancet and the New England Journal of Medicine.
MONDAY, Sept. 11, 2017 -- Nicotine in e-cigarettes may cause stiffened arteries, which can lead to an increased risk for heart attack and stroke, a small Swedish study suggests.
With the dramatic increase in e-cigarette use ("vaping") over the past few years, questions have arisen about their safety. And while many people think the devices are harmless, especially compared with regular cigarettes, little is known about long-term effects of these devices, according to lead researcher Magnus Lundback, from the Karolinska Institute in Stockholm.
WEDNESDAY, Aug. 16, 2017 -- Despite some early concerns, a new study suggests the powerful cholesterol drugs known as PCSK9 inhibitors may not cause memory problems or other mental symptoms.
The drugs, which include evolocumab (Repatha) and alirocumab (Praluent), were approved in the United States in 2015. That came after trials showed they can dramatically slash LDL cholesterol (the "bad" kind), including in people with a genetic condition that often causes premature heart disease.
THURSDAY, Aug. 17, 2017 -- Five years after heart bypass surgery, patients whose operation was done using a heart-lung pump lived longer than those whose surgeons didn't use the device, a new study finds.
Since the 1990s, two different approaches have been commonly used by heart surgeons to perform coronary artery bypass graft operations. Coronary artery bypass creates new routes for blood to flow to the heart because old routes are blocked by plaque in the artery. A piece of blood vessel is taken from another area of the body (often the leg) and used to "bypass" a blocked vessel going to the heart, according to the U.S. National Heart, Lung, and Blood Institute.
MONDAY, July 24, 2017 -- A wave of anti-science skepticism may put people with high cholesterol at risk if they're convinced to quit life-saving statin medications, heart experts warn.
An "internet-driven cult" is attacking the safety and effectiveness of cholesterol-lowering statins, despite mounds of clinical trial data showing the drugs work and produce minimal side effects, said Dr. Steven Nissen, chairman of cardiovascular medicine at the Cleveland Clinic.